ZACCARELLI, ELEONORA
 Distribuzione geografica
Continente #
NA - Nord America 394
EU - Europa 190
AS - Asia 79
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 670
Nazione #
US - Stati Uniti d'America 383
SE - Svezia 100
IN - India 32
CN - Cina 28
IT - Italia 28
FI - Finlandia 18
SG - Singapore 16
RO - Romania 14
CA - Canada 11
DE - Germania 8
GB - Regno Unito 8
FR - Francia 6
UA - Ucraina 5
JP - Giappone 3
EG - Egitto 2
IE - Irlanda 2
TG - Togo 2
AR - Argentina 1
CZ - Repubblica Ceca 1
EU - Europa 1
ZA - Sudafrica 1
Totale 670
Città #
Ashburn 50
Fairfield 50
Chandler 37
Woodbridge 30
Cambridge 27
Beijing 19
Wilmington 17
Houston 16
Ann Arbor 14
Plano 14
Princeton 14
Seattle 12
Millbury 9
Ottawa 9
San Paolo di Civitate 8
Lawrence 6
Norwalk 6
Boston 4
Singapore 4
Washington 4
Dallas 3
Dearborn 3
Hamadacho 3
Helsinki 3
Mumbai 3
Rome 3
Andover 2
Bühl 2
Cairo 2
Dublin 2
Grafing 2
Hefei 2
Lomé 2
London 2
Redwood City 2
San Diego 2
Southend 2
Toronto 2
Bangalore 1
Bremen 1
Brno 1
Chengdu 1
Chiswick 1
Des Moines 1
Dossenheim 1
Federal 1
Fremont 1
Guangzhou 1
Horia 1
Jinhua 1
Kunming 1
L'aquila 1
Leawood 1
Mannheim 1
Monmouth Junction 1
Nanchang 1
Paris 1
Pune 1
Shenyang 1
Silverton 1
Silvi 1
Zhengzhou 1
Totale 416
Nome #
Breast cancer during pregnancy 80
Triple-negative breast cancer: investigating potential molecular therapeutic target 75
null 55
Nonpegylated liposomal doxorubicin (nPLD) in neoadjuvant treatment of local advanced breast cancer (LABC) patients (pts) 53
BODY MASS INDEX (BMI) AND AMENORRHEA IN PREMENOPAUSAL BREAST CANCER PATIENTS (PBC) TREATED WITH ADJUVANT ANTRACYCLINE AND CYCLOPHOSPAMIDE CHEMOTHERAPY (CT) 48
null 48
null 45
EFFICACY AND SAFETY PROFILES OF PEGFILGRASTIM (P) AND LENOGRASTIM (L) IN NON METASTATIC BREAST CANCER (NMBC) PATIENTS RECEIVING ADJUVANT FEC100 43
Critical appraisal of bevacizumab in the treatment of metastatic colorectal cancer 38
Plerixafor and autologous stem cell transplantation: Impressive result in a chemoresistant testicular cancer patient treated with high-dose chemotherapy 37
null 33
null 29
KRAS genotypes and outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab. 28
null 20
Incidence of chemotherapy (CT) induced amenorrhea in premenopausal patients (pts) with breast cancer (BC) following adjuvant anthracycline (A), cyclophosphamide (C), and taxane (T) 20
Primary prophylaxis of neutropenia in women affected by breast cancer undergoing adjuvant chemotherapy with fec 100+/- docetaxel. Comparison of efficacy and tolerability between lenograstim and pegfilgrastim 19
Targeting angiogenesis in endometrial cancer - New agents for tailored treatments 18
Bevacizumab in ovarian cancer: A critical review of phase III studies 16
Efficacy, safety and cost-effectiveness (ce) analysis of lenograstim (l) versus pegfilgrastim (p) in management of chemotherapy related neutropenia (crn) in non metastatic breast cancer (bc) patients 16
Totale 721
Categoria #
all - tutte 2.084
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.084


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020116 0 0 2 5 10 13 18 18 18 15 9 8
2020/202148 11 7 2 3 4 6 0 3 4 7 0 1
2021/2022159 0 2 10 14 32 12 5 6 14 10 25 29
2022/2023179 41 51 15 4 24 11 13 5 12 0 3 0
2023/202477 3 9 9 5 14 16 0 4 1 6 5 5
2024/20257 2 5 0 0 0 0 0 0 0 0 0 0
Totale 721